Control | CC | WSC | |
---|---|---|---|
n Gender (male/female) | 20 11–9 | 17 10–7 | 10 4–6 |
Age (years) | 51.1 ± 3.6 | 58.4 ± 4.0 | 66.9 ± 4.3 |
BMI (kg/m2) | 23.3 ± 0.9 | 20.6 ± 0.8 | 22.9 ± 0.7 |
Weight loss (%) | 1.9 ± 1.0 | 19.9 ± 1.9a,b | 4.0 ± 0.5 |
Staging, n (%) | |||
IA | 0 (0) | 3 (30.0) | |
IB | 0 (0) | 0 (0) | |
IIA | 0 (0) | 0 (0) | |
IIB | 2 (11.7) | 1 (10.0) | |
IIIA | 4 (23.5) | 1 (10.0) | |
IIIB | 2 (11.7) | 1 (10.0) | |
IV | 9 (53.0) | 4 (40.0) | |
CRP (mg/dL) | 9.5 ± 6.8 | 92.3 ± 15.4b | 90.4 ± 31.2b |
Haemoglobin (g/dL) | 12.4 ± 0.5 | 11.4 ± 0.4 | 11.3 ± 0.6 |
Urea (mg/dL) | 36.9 ± 2.7 | 35.3 ± 6.5 | 36.9 ± 3.5 |
Free fatty acids (μM) | 680.9 ± 30.1 | 1786.9 ± 551.0b | 917.3 ± 43.3 |
Glucose (mM) | 5.51 ± 0.2 | 5.3 ± 0.2 | 6.01 ± 0.4 |
Insulin (ng/mL) | 0.5 ± 0.1 | 0.3 ± 0.1 | 0.6 ± 0.1 |
Cholesterol (mg/dL) | 183.9 ± 13.7 | 287.3 ± 65.2b | 300.0 ± 54.1b |
HDL(mg/dL) | 52.8 ± 3.3 | 42.8 ± 7.0 | 64.1 ± 9.9 |
VLDL (mg/dL) | 29.5 ± 1.5 | 28.5 ± 0.6a | 36.4 ± 3.0 |
LDL (mg/dL) | 104.0 ± 11.6 | 239.8 ± 54.1b | 200.3 ± 42.4b |
Triacylglycerol (mg/dL) | 147.8 ± 9.2 | 142.6 ± 3.8 | 182.1 ± 17.9 |